GlassScriptPhysician profile
Michael C Longley
NPI 1770586182
$1,340.32
in general payments reported to CMS, 2019-2025
18 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $84.87 · 2021: $62.82 · 2022: $134 · 2023: $524 · 2024: $77.64 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $494.77 | 2021-2024 | Navlock, Mazor X System, Catalyft Pl Expandable Interbody System |
| Orthofix Medical, INC. | $170.35 | 2019-2025 | Spinal-Stim |
| Zimvie INC. | $126.13 | 2023 | |
| Aesculap Implant Systems, LLC | $78.12 | 2019 | |
| Globus Medical, INC. | $68.00 | 2023 | Excelsiusgps Robotic Navigation System |
| Vertex Pharmaceuticals Incorporated | $65.35 | 2025 | |
| Baxter Healthcare | $48.34 | 2019 | |
| Nuvasive, INC. | $46.96 | 2022 | |
| Medtronic USA, INC. | $37.59 | 2019 | |
| Cerapedics INC. | $33.70 | 2019-2025 | I-Factor Peptide Enhanced Bone Graft |
| Boston Scientific Corporation | $31.80 | 2019-2020 | |
| Si-Bone, INC. | $30.62 | 2023-2025 | |
| Centinel Spine, LLC | $24.37 | 2019 | |
| Spineology INC. | $21.30 | 2021 | |
| Amgen INC. | $21.20 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $14.37 | 2020 | |
| Solventum Corporation | $13.75 | 2024 | V.A.C. Veraflo, Activ.A.C., Prevena |
| Ultragenyx Pharmaceutical INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Longley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.